4
Changes in Ownership
CURIS INC Filed Acc 0001181431-08-005755
Options or other derivatives
- VP, Research & Preclinical Dev acquired 180,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Qian Changgeng VP, Research & Preclinical Dev | 2008-01-25 | Grant or award · Qualified stock option (right to buy) | +55,075 | 55,075 | D: show line 1 in the form | |||||
| Qian Changgeng VP, Research & Preclinical Dev | 2008-01-25 | Grant or award · Non-qualified stock option (right to buy) | +124,925 | 124,925 | D: show line 2 in the form |
Loading xslF345X02/rrd192116.xml…